Previous close | 30.05 |
Open | 30.05 |
Bid | 24.60 |
Ask | 25.95 |
Strike | 130.00 |
Expiry date | 2024-06-21 |
Day's range | 30.05 - 30.05 |
Contract range | N/A |
Volume | |
Open interest | 1.02k |
Moderna (MRNA) posts data on three experimental vaccines and intends to advance them to late-stage studies. It also secures $750 million in funding from Blackstone to advance its influenza program.
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.